Prader-Willi syndrome: Clinical genetics and diagnostic aspects with treatment approaches

Current Pediatric Reviews

Volumn 12, Issue 2, 2016, Pages 136-166

  Butler, Merlin G ^a   Manzardo, Ann M ^a   Forster, Janice L ^b  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Diagnostic and treatment approaches; Genetic testing; Genetics clinical description of Prader Willi syndrome; Genomic imprinting; Medical management; Obesity; Prader Willi syndrome

Indexed keywords

ACETYLCYSTEINE; AMPHETAMINE PLUS DEXAMPHETAMINE; ATOMOXETINE; CARBAMAZEPINE; CITALOPRAM; DEXAMPHETAMINE; ESCITALOPRAM; ESTRADIOL; FLUOXETINE; FLUVOXAMINE; GESTAGEN; HUMAN GROWTH HORMONE; LAMOTRIGINE; LISDEXAMFETAMINE; METHYLPHENIDATE; MODAFINIL; MOOD STABILIZER; NEUROLEPTIC AGENT; OMEGA 3 FATTY ACID; OXCARBAZEPINE; PAROXETINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SOMATOMEDIN C; TESTOSTERONE ENANTATE; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID; VITAMIN D;

ADENOIDECTOMY; ATTENTION DEFICIT DISORDER; CHROMOSOME 15; CLINICAL GENETICS; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; COMORBIDITY; CONTROLLED CLINICAL TRIAL (TOPIC); DUAL ENERGY X RAY ABSORPTIOMETRY; EYE SURGERY; FAILURE TO THRIVE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENETIC SCREENING; GENOME IMPRINTING; GLUCOSE TOLERANCE TEST; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPERPHAGIA; HYPOGONADISM; HYPOTHALAMUS DISEASE; INFANTILE HYPOTONIA; META ANALYSIS (TOPIC); MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; MULTICENTER STUDY (TOPIC); MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; OBESITY; OBSESSIVE COMPULSIVE DISORDER; ORTHOPEDIC SURGERY; PATIENT EDUCATION; PATIENT SATISFACTION; POLYSOMNOGRAPHY; PRACTICE GUIDELINE; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROBLEM BEHAVIOR; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCOLIOSIS; SPEECH THERAPY; SYSTEMATIC REVIEW (TOPIC); THYROID FUNCTION TEST; TONSILLECTOMY; UNIPARENTAL DISOMY; CHILD; DEVELOPMENTAL DISORDER; GENE EXPRESSION PROFILING; GENETIC COUNSELING; GENETICS; PATHOPHYSIOLOGY; PHENOTYPE; PRADER-WILLI SYNDROME; PRESCHOOL CHILD; PROGNOSIS;

CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; DEVELOPMENTAL DISABILITIES; GENE EXPRESSION PROFILING; GENETIC COUNSELING; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERPHAGIA; OBESITY; PHENOTYPE; PRACTICE GUIDELINES AS TOPIC; PRADER-WILLI SYNDROME; PROGNOSIS;

DISEASE TREATMENT; GENE EXPRESSION; GENETIC ANALYSIS; GROWTH RESPONSE; HORMONE; MORBIDITY; MORTALITY; OBESITY;

EID: 84974676910     PISSN: 15733963     EISSN: 18756336     Source Type: Journal    
DOI: 10.2174/1573396312666151123115250     Document Type: Review

References (75)

1. Butler MG. Prader-Willi syndrome: Current understanding of cause and diagnosis. Am J Med Genet 1990; 35: 319-32.
2. Butler MG, Lee PDK, Whitman BY. Management of Prader-Willi Syndrome. 3rd ed New York, NY: Springer Verlag Inc 2006.
3. Butler MG. Prader-Willi syndrome: Obesity due to genomic imprinting. Curr Genomics 2011; 12(3): 204-15.
4. Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med 2012; 14: 10-26.
5. Angulo M, Butler MG, Cataletto M. Prader-Willi syndrome: A review of clinical, genetic and endocrine findings. J Endocrinol Invest, 2015 Dec; 38(12):1249-63.
6. Butler MG, Cassidy SB. Genetic basis, genetic testing and genetic counseling for Prader-Willi syndrome. In: Prader-Willi Syndrome. C. Hoybye (ed.) Nova Science Publishers Inc Hauppauge NY 2013.
7. Dykens EM. Are jigsaw puzzle skills ‘spared’ in persons with Prader-Willi syndrome? J Child Psychol Psychiatry. 2002 Mar;43(3):343-52.
8. Roof E, Stone W, MacLean W, Feurer ID, Thompson T, Butler MG. Intellectual characteristics of Prader-Willi syndrome: comparison of genetic subtypes. J Intellect Disabil Res. 2000 Feb; 44 (Pt 1):25-30.
9. Soni S, Whittington J, Holland AJ, et al. The course and outcome of psychiatric illness in people with Prader-Willi syndrome: implications for management and treatment. J Intellect Disabil Res. 2007 Jan;51(Pt 1):32-42.
10. Soni S, Whittington J, Holland AJ, et al. The phenomenology and diagnosis of psychiatric illness in people with Prader-Willi syndrome. Psychol Med. 2008 Oct; 38(10):1505-14.
11. Butler MG, Bittel DC, Kibiryeva N, Talebizadeh Z, Thompson T. Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics 2004; 113: 565-73.
12. Zarcone J, Napolitano D, Peterson C, et al. The relationship between compulsive behavior and academic achievement across the three genetic subtypes of Prader-Willi syndrome. J Intellect Disabil Res 2007; 51: 478-87.
13. Boer H, Holland A, Whittington J, Butler J, Webb T, Clarke D. Psychotic illness in people with Prader-Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet. 2002 Jan; 359(9301):135-6.
14. Holm VA, Cassidy SB, Butler MG, et al. Prader-Willi syndrome: Consensus diagnostic criteria. Pediatrics 1993; 91: 398-402.
15. Gunay-Aygun M, Schwartz S, Heeger S, O'Riordan MA, Cassidy SB. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics. 2001 Nov;108(5):E92.
16. Ledbetter DH, Riccardi VM, Airhart SD, Strobel RJ, Keenan BS, Crawford JD. Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. N Engl J Med. 1981 Feb; 304(6):325-9.
17. Butler MG, Palmer CG. Parental origin of chromosome 15 deletion in Prader-Willi syndrome. Lancet. 1983 Jun; 1(8336):1285-6.
18. Nicholls RD, Knoll JH, Butler MG, Karam S, Lalande M. Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. Nature 1989; 342: 281-5.
19. Ohta T, Gray TA, Rogan PK, et al. Imprinting-mutation mechanisms in Prader-Willi syndrome. Am J Hum Genet 1999; 64: 397-413.
20. Buiting K, Gross S, Lich C, Gillessen-Kaesbach G, el-Maarri O, Horsthemke B. Epimutations in Prader-Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect. Am J Hum Genet. 2003 Mar; 72(3):571-7.
21. Bittel DC, Butler MG. Prader-Willi syndrome: Clinical genetics, cytogenetics and molecular biology. Expert Rev Mol Med 2005; 7: 1-20.
22. Newkirk HL, Bittel DC, Butler MG. Analysis of the Prader-Willi syndrome chromosome region using quantitative microsphere hybridization (QMH) array. Am J Med Genet A. 2008 Sep 15;146A(18):2346-54.
23. Goldstone AP, Holland AJ, Hauffa BP, et al. Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab. 2008 Nov; 93(11):4183-97.
24. McCandless SE, Saal HM, Braddock SR, et al. Clinical report— health supervision for children with Prader-Willi syndrome. Pediatrics. 2011 Jan; 127(1):195-204.
25. Miller JL, Lynn CH, Driscoll DC, et al. Nutritional phases in Prader-Willi syndrome. Am J Med Genet 2011; 155A: 1040-9.
26. Griggs J, Sinnayah P, Mathai ML. Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments. Neurosci Biobehav Rev. 2015 Oct 16. pii: S0149-7634(15)00263-8.
27. Butler MG, Christian SL, Kubota T, Ledbetter DH. A 5-year-old white girl with Prader-Willi syndrome and a submicroscopic deletion of chromosome 15q11q 13. Am J Med Genet. 1996 Oct;65(2):137-41.
28. Sahoo T, del Gaudio D, German JR, et al. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet. 2008 Jun; 40(6):719-21.
29. Kim SJ, Miller JL, Kuipers PJ, et al. Unique and atypical deletions in Prader-Willi syndrome reveal distinct phenotypes. Eur J Hum Genet. 2012 Mar;20(3):283-90.
30. Butler MG, Sturich J, Myers SE, Gold JA, Kimonis V, Driscoll DJ. Is gestation in Prader-Willi syndrome affected by the genetic subtype? J Assist Reprod Genet. 2009 Aug;26(8):461-6.
31. Butler MG, Meaney FJ, Palmer CG. Clinical and cytogenetic survey of 39 individuals with Prader-Labhart-Willi syndrome. Am J Med Genet. 1986 Mar; 23(3):793-809.
32. Butler MG, Thompson T. Prader-Willi syndrome: Clinical and genetic findings. Endocrinology 2000; 10:2S-16S.
33. Butler MG, Weaver DD, Meaney FJ. Prader-Willi syndrome: Are there population differences? Clin Genet. 1982 Nov; 22(5):292-4
34. Whittington J, Holland A, Webb T, Butler J, Clarke D, Boer H. Cognitive abilities and genotype in a population-based sample of people with Prader-Willi syndrome. J Intellect Disabil Res 2004; 48: 172-87.
35. Butler MG, Fischer W, Kibiryeva N, Bittel DC. Array comparative genomic hybridization (aCGH) analysis in Prader-Willi syndrome. Am J Med Genet A. 2008 Apr 1;146A(7):854-60.
36. Butler MG, Theodoro MF, Bittel DC, Kuipers PJ, Driscoll DJ, Talebizadeh Z. X-chromosome inactivation patterns in females with Prader-Willi syndrome. Am J Med Genet A. 2007 Mar;143A(5):469-75.
37. Yang T, Adamson TE, Resnick JL, et al. A mouse model for Prader-Willi syndrome imprinting-centre mutations. Nat Genet. 1998 May;19(1):25-31.
38. Francis SM, Sagar A, Levin-Decanini T, Liu W, Carter CS, Jacob S. Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders. Brain Res. 2014 Sep;1580: 199-218.
39. Johnson L, Manzardo AM, Miller JL, Driscoll DJ, Butler MG. Elevated plasma oxytocin levels in children with Prader-Willi syndrome compared with healthy unrelated siblings. Am J Med Genet A. 2015 Nov 30. doi: 10.1002/ajmg.a.37488. [Epub ahead of print].
40. Butler MG, Nelson TA, Driscoll DJ, Manzardo AM. Evaluation of plasma substance P and beta-endorphin levels in children with Prader-Willi syndrome. J Rare Disease, 2015; 3(2): 1-10.
41. Butler MG, Nelson TA, Driscoll DJ, Manzardo AM. High plasma neurotensin levels in children with Prader-Willi syndrome. Am J Med Genet A. 2015 Aug; 167A(8): 1773-8.
42. Cruvinel E, Budinetz T, Germain N, Chamberlain S, Lalande M, Martins-Taylor K. Reactivation of maternal SNORD116 cluster via SETDB1 knockdown in Prader-Willi syndrome iPSCs. Hum Mol Genet. 2014 Sep;23(17):4674-85.
43. Holsen LM, Zarcone JR, Brooks WM, et al. Neural mechanisms underlying hyperphagia in Prader-Willi syndrome. Obesity (Silver Spring) 2006; 14: 1028-37.
44. Cassidy SB, Lai LW, Erickson RP, et al. Trisomy 15 with loss of the paternal 15 as a cause of Prader-Willi syndrome due to maternal disomy. Am J Hum Genet. 1992 Oct; 51(4): 701-8.
45. Butler MG. Genomic imprinting disorders in humans: A minireview. J Assist Reprod Genet. 2009 Sep-Oct; 26(9-10): 477-86.
46. Gold JA, Ruth C, Osann K, et al. Frequency of Prader-Willi syndrome in births conceived via assisted reproductive technology. Genet Med. 2014 Feb;16(2):164-9.
47. Irizarry KA, Bain J, Butler MG, et al. Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone. Clin Endocrinol (Oxf). 2015 Mar 4. doi: 10.1111/cen.12766. [Epub ahead of print]
48. Butler MG, Theodoro M, Skouse JD. Thyroid function studies in Prader-Willi syndrome. Am J Med Genet A. 2007 Mar; 143A(5): 488-92.
49. Butler MG, Hayes BG, Hathaway MM, Begleiter ML. Specific genetic diseases at risk for sedation/anesthesia complications. Anesth Analg. 2000 Oct; 91(4):837-55.
50. Stevenson DA, Heinemann J, Angulo M, et al. Gastric rupture and necrosis in Prader-Willi syndrome. J Pediatr Gastroenterol Nutr 2007; 45: 272-4.
51. Lo ST, Collin PJ, Hokken-Koelega AC. Psychiatric disorders in children with Prader-Willi syndrome-Results of a 2-year longitudinal study. Am J Med Genet A. 2015 May;167A(5):983-91.
52. Papenhausen P, Schwartz S, Risheg H, et al. UPD detection using homozygosity profiling with a SNP genotyping microarray. Am J Med Genet A. 2011 Apr; 155A(4):757-68.
53. Bittel DC, Kibiryeva N, Butler MG. Methylation-specific multiplex ligation-dependent probe amplification analysis of subjects with chromosome 15 abnormalities. Genet Test. 2007 Winter;11(4):467-75.
54. Henkhaus RS, Kim SJ, Kimonis VE, et al. Methylation-specific multiplex ligation-dependent probe amplification and identification of deletion genetic subtypes in Prader-Willi syndrome. Genet Test Mol Biomarkers. 2012 Mar;16(3):178-86.
55. Butler MG. Molecular diagnosis of Prader-Willi syndrome: comparison of cytogenetic and molecular genetic data including parent of origin dependent methylation DNA patterns. Am J Med Genet. 1996 Jan; 61(2):188-90.
56. Deal CL, Tony M, Hoybye C, Allen DB, Tauber M, Christiansen JS. Growth Hormone Research Society workshop summary: Consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab 2013; 98: E1072-87.
57. Butler MG, Haber L, Mernaugh R, Carlson MG, Price R, Feurer ID. Decreased bone mineral density in Prader-Willi syndrome: comparison with obese subjects. Am J Med Genet. 2001 Oct;103(3):216-22.
58. Jones KL, ed. Smith’s Recognizable Patterns of Human Malformation. 6th ed. Philadelphia: W.B. Saunders Company; 2006. p. 1–954.
59. Choquet H, Meyre D. Genetics of obesity: What have we learned? Curr Genomics. 2011 May;12(3):169-79.
60. Choquet H, Meyre D. Molecular basis of obesity: Current status and future prospects. Curr Genomics. 2011 May;12(3):154-68.
61. Butler MG, Wang K, Marshall JD et al. Coding and noncoding expression patterns associated with rare obesity-related disorders: Prader-Willi and Alström syndromes. Adv Genomics Genet. 2015; 2015(5):53-75.
62. Dasouki MJ, Youngs EL, Hovanes K. Structural chromosome abnormalities associated with obesity: report of four new subjects and review of literature. Curr Genomics. 2011 May; 12(3): 190-203.
63. Butler MG, McGuire A, Manzardo AM. Clinically relevant known and candidate genes for obesity and their overlap with human infertility and reproduction. J Assist Reprod Genet. 2015 Apr; 32(4): 495-508.
64. Smith T, Sharp S, Manzardo AM, Butler MG. Pharmacogenetics informed decision making in adolescent psychiatric treatment: a clinical case report. Int J Mol Sci. 2015 Feb 20; 16(3):4416-28.
65. Butler MG, Sturich J, Lee J, et al. Growth standards in infants with Prader-Willi syndrome. Pediatrics 2011; 127(4): 687-95.
66. Butler MG. Management of obesity in Prader-Willi syndrome. Nat Clin Pract Endocrinol Metab. 2006 Nov; 2(11): 592-3.
67. Salehi P, Leavitt A, Beck AE, Chen ML, Roth CL. Obesity management in Prader-Willi syndrome. Pediatr Endocrinol Rev. 2015 Mar; 12(3):297-307.
68. Emerick JE, Vogt KS. Endocrine manifestations and management of Prader-Willi syndrome. Int J Pediatr Endocrinol. 2013 Aug 21;2013(1):14.
69. Sanchez-Ortiga R, Klibanski A, Tritos NA. Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis. Clin Endocrinol. 2012; 77:86-93
70. de Lind van Wijngaarden RF, Siemensma EP, Festen DA et al. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome. J Clin Endocrinol Metab. 2009; 94: 4205-15
71. Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA et al. Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: A randomized controlled trial and longitudinal study. J Clin Endocrinol Metab. 2012; 97:2307-14
72. Miller JL, Angulo M. An open-label pilot study of N-acetylcysteine for skin-picking in Prader-Willi syndrome. Am J Med Genet A. 2014; 164A(2): 421-4.
73. Butler MG, Lee J, Manzardo AM, et al. Growth charts for nongrowth hormone treated Prader-Willi syndrome. Pediatrics 2015; 135: e126-135.
74. Butler MG, Lee J, Cox DM, et al. Growth charts for Prader-Willi syndrome during growth hormone treatment, Clin Pediatri, in press.
75. Stevenson DA, Heinemann J, Angulo M, et al. Deaths due to choking in Prader-Willi syndrome. Am J Med Genet A 1 2007; 143: 484-7.